Gene Symbol | Gene ID | Gene Info |
---|---|---|
TAL1
|
ENSG00000162367.7 | TAL bHLH transcription factor 1, erythroid differentiation factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_47701396_47701568 | TAL1 | 4095 | 0.184064 | 0.83 | 5.2e-03 | Click! |
chr1_47707019_47707170 | TAL1 | 9707 | 0.155828 | 0.83 | 6.1e-03 | Click! |
chr1_47698792_47698943 | TAL1 | 1480 | 0.348008 | 0.81 | 8.3e-03 | Click! |
chr1_47700782_47700933 | TAL1 | 3470 | 0.196110 | 0.76 | 1.7e-02 | Click! |
chr1_47707385_47707536 | TAL1 | 10073 | 0.155176 | 0.76 | 1.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_42106310_42106729 | 1.14 |
ENSG00000223245 |
. |
8108 |
0.23 |
chr17_9889618_9890151 | 1.13 |
GAS7 |
growth arrest-specific 7 |
27105 |
0.19 |
chr17_61477281_61477632 | 1.04 |
TANC2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
4352 |
0.16 |
chr5_158272761_158273239 | 1.01 |
CTD-2363C16.1 |
|
137014 |
0.05 |
chr3_49846473_49846624 | 1.00 |
ENSG00000263506 |
. |
2870 |
0.12 |
chr3_71440657_71441270 | 0.97 |
FOXP1 |
forkhead box P1 |
87052 |
0.09 |
chr9_92771423_92771933 | 0.97 |
ENSG00000263967 |
. |
14139 |
0.32 |
chr4_185704355_185704660 | 0.96 |
ACSL1 |
acyl-CoA synthetase long-chain family member 1 |
9480 |
0.19 |
chr17_3865194_3865538 | 0.94 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
2219 |
0.29 |
chr15_40600368_40600571 | 0.94 |
PLCB2 |
phospholipase C, beta 2 |
346 |
0.74 |
chr11_44936863_44937276 | 0.92 |
TSPAN18 |
tetraspanin 18 |
9111 |
0.25 |
chr5_75621996_75622528 | 0.89 |
RP11-466P24.6 |
|
14975 |
0.27 |
chr5_58474357_58474721 | 0.89 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
97406 |
0.09 |
chr2_65245457_65245908 | 0.89 |
AC007386.4 |
|
18949 |
0.14 |
chr5_138414055_138414601 | 0.88 |
SIL1 |
SIL1 nucleotide exchange factor |
35957 |
0.15 |
chr8_125575470_125576116 | 0.88 |
MTSS1 |
metastasis suppressor 1 |
2175 |
0.26 |
chr2_7148460_7148835 | 0.84 |
RNF144A |
ring finger protein 144A |
11576 |
0.24 |
chr19_6276365_6276592 | 0.84 |
MLLT1 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 |
3481 |
0.18 |
chr1_108327675_108328746 | 0.83 |
ENSG00000265536 |
. |
9332 |
0.26 |
chr1_230279012_230279387 | 0.82 |
GALNT2 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
76181 |
0.1 |
chr5_147183992_147184208 | 0.82 |
JAKMIP2 |
janus kinase and microtubule interacting protein 2 |
21762 |
0.17 |
chr17_78845626_78846398 | 0.81 |
RPTOR |
regulatory associated protein of MTOR, complex 1 |
50512 |
0.1 |
chr21_43843966_43844673 | 0.79 |
ENSG00000252619 |
. |
6617 |
0.14 |
chr22_37667791_37668055 | 0.79 |
CYTH4 |
cytohesin 4 |
10145 |
0.16 |
chr5_139035453_139035988 | 0.79 |
CXXC5 |
CXXC finger protein 5 |
3420 |
0.27 |
chr10_101604205_101604725 | 0.79 |
DNMBP |
dynamin binding protein |
53554 |
0.11 |
chr15_66966924_66967543 | 0.78 |
SMAD6 |
SMAD family member 6 |
27333 |
0.18 |
chr6_6588340_6588548 | 0.77 |
LY86 |
lymphocyte antigen 86 |
103 |
0.95 |
chr1_167509501_167509771 | 0.77 |
CREG1 |
cellular repressor of E1A-stimulated genes 1 |
13368 |
0.19 |
chr18_457195_458136 | 0.77 |
RP11-720L2.2 |
|
33249 |
0.16 |
chr19_52124679_52125032 | 0.77 |
SIGLEC5 |
sialic acid binding Ig-like lectin 5 |
8733 |
0.11 |
chr2_55339476_55339889 | 0.77 |
RTN4 |
reticulon 4 |
75 |
0.97 |
chrX_77913775_77914536 | 0.76 |
ZCCHC5 |
zinc finger, CCHC domain containing 5 |
670 |
0.82 |
chr6_14884243_14884494 | 0.76 |
ENSG00000242989 |
. |
228831 |
0.02 |
chr6_126130986_126131446 | 0.76 |
NCOA7 |
nuclear receptor coactivator 7 |
65 |
0.97 |
chr11_46352086_46352730 | 0.75 |
DGKZ |
diacylglycerol kinase, zeta |
2047 |
0.27 |
chr16_85117176_85117574 | 0.75 |
KIAA0513 |
KIAA0513 |
5350 |
0.23 |
chr22_46635837_46636546 | 0.74 |
CDPF1 |
cysteine-rich, DPF motif domain containing 1 |
7991 |
0.15 |
chr7_26582997_26583253 | 0.74 |
KIAA0087 |
KIAA0087 |
4718 |
0.31 |
chr8_20987611_20987997 | 0.74 |
ENSG00000215945 |
. |
25838 |
0.28 |
chr11_112748912_112749352 | 0.74 |
RP11-629G13.1 |
|
82889 |
0.09 |
chr20_20374331_20374710 | 0.74 |
INSM1 |
insulinoma-associated 1 |
25755 |
0.22 |
chr9_80912339_80912560 | 0.74 |
PSAT1 |
phosphoserine aminotransferase 1 |
390 |
0.91 |
chr13_110350442_110350593 | 0.74 |
LINC00676 |
long intergenic non-protein coding RNA 676 |
30112 |
0.24 |
chr1_204432309_204432671 | 0.73 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
3984 |
0.23 |
chr18_5515876_5516076 | 0.73 |
EPB41L3 |
erythrocyte membrane protein band 4.1-like 3 |
5446 |
0.21 |
chr2_55346845_55347305 | 0.73 |
RTN4 |
reticulon 4 |
7318 |
0.2 |
chr16_90077131_90077487 | 0.73 |
DBNDD1 |
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
690 |
0.55 |
chr20_31252924_31253424 | 0.72 |
RP11-410N8.4 |
|
63735 |
0.09 |
chr8_123800044_123800223 | 0.72 |
ZHX2 |
zinc fingers and homeoboxes 2 |
6500 |
0.22 |
chr14_93035282_93035696 | 0.72 |
RIN3 |
Ras and Rab interactor 3 |
55341 |
0.15 |
chr8_27468139_27468395 | 0.72 |
CLU |
clusterin |
455 |
0.82 |
chr7_157182751_157183382 | 0.72 |
DNAJB6 |
DnaJ (Hsp40) homolog, subfamily B, member 6 |
50551 |
0.15 |
chr13_30071250_30071401 | 0.71 |
MTUS2-AS1 |
MTUS2 antisense RNA 1 |
7083 |
0.28 |
chr10_126318429_126318696 | 0.71 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
73632 |
0.1 |
chr6_37939838_37940078 | 0.71 |
ZFAND3 |
zinc finger, AN1-type domain 3 |
42223 |
0.17 |
chr1_181097672_181097949 | 0.71 |
IER5 |
immediate early response 5 |
40172 |
0.18 |
chr8_130566904_130567142 | 0.70 |
ENSG00000266387 |
. |
57110 |
0.09 |
chr17_10019598_10019977 | 0.70 |
GAS7 |
growth arrest-specific 7 |
1917 |
0.36 |
chr18_76402714_76403159 | 0.70 |
ENSG00000201723 |
. |
98748 |
0.09 |
chr19_47126907_47127137 | 0.70 |
PTGIR |
prostaglandin I2 (prostacyclin) receptor (IP) |
1272 |
0.26 |
chr9_93578039_93578557 | 0.69 |
SYK |
spleen tyrosine kinase |
11472 |
0.32 |
chr11_120096021_120096283 | 0.69 |
POU2F3 |
POU class 2 homeobox 3 |
11197 |
0.16 |
chr10_134235955_134236340 | 0.69 |
RP11-432J24.3 |
|
18841 |
0.16 |
chr2_47284202_47284907 | 0.69 |
AC073283.7 |
|
10407 |
0.19 |
chr2_58960903_58961313 | 0.69 |
FANCL |
Fanconi anemia, complementation group L |
492601 |
0.0 |
chr14_89819638_89820075 | 0.68 |
RP11-356K23.2 |
|
1548 |
0.36 |
chr13_96421991_96422142 | 0.68 |
ENSG00000251901 |
. |
55034 |
0.15 |
chr21_44994556_44994959 | 0.68 |
HSF2BP |
heat shock transcription factor 2 binding protein |
83268 |
0.08 |
chr10_134364617_134365046 | 0.68 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
13188 |
0.21 |
chr7_29995969_29996337 | 0.67 |
SCRN1 |
secernin 1 |
1295 |
0.44 |
chr20_47449148_47449557 | 0.67 |
PREX1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
4932 |
0.3 |
chr6_36445894_36446179 | 0.67 |
ENSG00000240733 |
. |
27058 |
0.11 |
chr3_4574666_4574817 | 0.67 |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
16565 |
0.23 |
chr12_2725371_2725522 | 0.67 |
CACNA1C-AS3 |
CACNA1C antisense RNA 3 |
8840 |
0.23 |
chr3_108539430_108540262 | 0.67 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
1699 |
0.47 |
chr7_129278146_129278355 | 0.67 |
NRF1 |
nuclear respiratory factor 1 |
8341 |
0.24 |
chr10_80503069_80503410 | 0.67 |
ENSG00000223243 |
. |
7120 |
0.33 |
chr20_50647859_50648222 | 0.66 |
ZFP64 |
ZFP64 zinc finger protein |
66965 |
0.12 |
chr12_89453867_89454269 | 0.66 |
ENSG00000238302 |
. |
221994 |
0.02 |
chr16_88989864_88990015 | 0.65 |
RP11-830F9.7 |
|
14225 |
0.11 |
chr21_43532368_43532519 | 0.65 |
C21orf128 |
chromosome 21 open reading frame 128 |
3799 |
0.25 |
chr9_136208794_136209274 | 0.65 |
ENSG00000201451 |
. |
4373 |
0.07 |
chr20_40036341_40036492 | 0.65 |
EMILIN3 |
elastin microfibril interfacer 3 |
40949 |
0.15 |
chr1_155938649_155938876 | 0.65 |
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
758 |
0.45 |
chr1_181099584_181099735 | 0.65 |
IER5 |
immediate early response 5 |
42021 |
0.17 |
chr16_11504956_11505107 | 0.65 |
CTD-3088G3.8 |
Protein LOC388210 |
12665 |
0.13 |
chr2_207385944_207386095 | 0.65 |
ADAM23 |
ADAM metallopeptidase domain 23 |
73540 |
0.09 |
chr20_55059757_55060025 | 0.65 |
ENSG00000238294 |
. |
9192 |
0.13 |
chr9_130474440_130474591 | 0.65 |
C9orf117 |
chromosome 9 open reading frame 117 |
346 |
0.77 |
chr21_43575135_43575286 | 0.64 |
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
44589 |
0.12 |
chr11_18387325_18387856 | 0.64 |
GTF2H1 |
general transcription factor IIH, polypeptide 1, 62kDa |
14471 |
0.11 |
chr21_25648617_25648896 | 0.64 |
ENSG00000232512 |
. |
824689 |
0.0 |
chr15_74607384_74607800 | 0.64 |
CCDC33 |
coiled-coil domain containing 33 |
3308 |
0.2 |
chr9_100692681_100693016 | 0.64 |
C9orf156 |
chromosome 9 open reading frame 156 |
7996 |
0.15 |
chr6_109774911_109775484 | 0.64 |
MICAL1 |
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
1728 |
0.23 |
chr16_85481767_85482285 | 0.64 |
ENSG00000264203 |
. |
6928 |
0.27 |
chrX_19893812_19894177 | 0.64 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
11583 |
0.26 |
chr9_130473946_130474307 | 0.63 |
C9orf117 |
chromosome 9 open reading frame 117 |
43 |
0.95 |
chr15_91126847_91126998 | 0.63 |
CRTC3 |
CREB regulated transcription coactivator 3 |
10023 |
0.16 |
chr7_142998798_142999087 | 0.63 |
ENSG00000240322 |
. |
3333 |
0.12 |
chr5_153614743_153615024 | 0.63 |
GALNT10 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
44549 |
0.16 |
chr18_3713102_3713253 | 0.63 |
RP11-874J12.3 |
|
58253 |
0.1 |
chr16_78229110_78229406 | 0.63 |
RP11-190D6.2 |
|
45857 |
0.18 |
chr3_53727157_53727308 | 0.63 |
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
26804 |
0.2 |
chr1_21580844_21580995 | 0.63 |
RP3-329E20.2 |
|
11656 |
0.18 |
chr2_25346721_25347157 | 0.63 |
EFR3B |
EFR3 homolog B (S. cerevisiae) |
2397 |
0.3 |
chr13_101325397_101325635 | 0.63 |
TMTC4 |
transmembrane and tetratricopeptide repeat containing 4 |
1512 |
0.47 |
chr16_78402274_78402828 | 0.63 |
RP11-190D6.2 |
|
127436 |
0.05 |
chr14_89657538_89657839 | 0.63 |
FOXN3 |
forkhead box N3 |
10600 |
0.29 |
chr10_89805293_89806077 | 0.63 |
ENSG00000200891 |
. |
51233 |
0.16 |
chr19_10895125_10895440 | 0.62 |
DNM2 |
dynamin 2 |
1590 |
0.27 |
chr7_142424661_142424832 | 0.62 |
PRSS1 |
protease, serine, 1 (trypsin 1) |
32573 |
0.16 |
chr12_2799128_2799451 | 0.62 |
CACNA1C-AS1 |
CACNA1C antisense RNA 1 |
995 |
0.55 |
chr5_171332963_171333203 | 0.62 |
FBXW11 |
F-box and WD repeat domain containing 11 |
71677 |
0.11 |
chr2_111634520_111635040 | 0.62 |
ACOXL |
acyl-CoA oxidase-like |
71884 |
0.12 |
chr4_185811063_185811412 | 0.62 |
ENSG00000266698 |
. |
38973 |
0.14 |
chr1_208060057_208060208 | 0.62 |
CD34 |
CD34 molecule |
3705 |
0.34 |
chr14_105124368_105124519 | 0.62 |
ENSG00000265291 |
. |
19643 |
0.13 |
chr9_138923653_138924045 | 0.62 |
NACC2 |
NACC family member 2, BEN and BTB (POZ) domain containing |
18577 |
0.2 |
chr7_35686354_35686780 | 0.62 |
HERPUD2 |
HERPUD family member 2 |
47609 |
0.16 |
chr12_10219891_10220230 | 0.62 |
ENSG00000223042 |
. |
16725 |
0.12 |
chr9_21119427_21119782 | 0.61 |
IFNW1 |
interferon, omega 1 |
22540 |
0.12 |
chr7_102066247_102066509 | 0.61 |
ORAI2 |
ORAI calcium release-activated calcium modulator 2 |
7175 |
0.09 |
chr6_11310199_11310543 | 0.61 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
72161 |
0.11 |
chr18_46224612_46224763 | 0.61 |
RP11-426J5.2 |
|
9897 |
0.24 |
chr19_5074124_5074359 | 0.61 |
KDM4B |
lysine (K)-specific demethylase 4B |
8222 |
0.24 |
chr2_159986398_159986549 | 0.61 |
ENSG00000202029 |
. |
102819 |
0.07 |
chr11_9769419_9769570 | 0.61 |
SBF2-AS1 |
SBF2 antisense RNA 1 |
10345 |
0.18 |
chr19_16482714_16483205 | 0.61 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
10195 |
0.15 |
chr1_161321627_161321983 | 0.61 |
C1orf192 |
chromosome 1 open reading frame 192 |
15859 |
0.13 |
chr12_1739531_1740003 | 0.61 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
211 |
0.94 |
chr18_10402080_10402231 | 0.61 |
ENSG00000239031 |
. |
12158 |
0.26 |
chr22_47069281_47069627 | 0.61 |
GRAMD4 |
GRAM domain containing 4 |
1051 |
0.6 |
chr8_60020334_60021033 | 0.61 |
RP11-25K19.1 |
|
10916 |
0.2 |
chr9_84303303_84303539 | 0.61 |
TLE1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
58 |
0.98 |
chr20_33754417_33754601 | 0.60 |
PROCR |
protein C receptor, endothelial |
5367 |
0.14 |
chr3_193518427_193518715 | 0.60 |
ENSG00000243991 |
. |
60061 |
0.14 |
chr2_198127644_198128365 | 0.60 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
39239 |
0.13 |
chr6_39058213_39058364 | 0.60 |
SAYSD1 |
SAYSVFN motif domain containing 1 |
19060 |
0.22 |
chr1_156830671_156830822 | 0.60 |
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
60 |
0.95 |
chr17_78605857_78606085 | 0.60 |
RPTOR |
regulatory associated protein of MTOR, complex 1 |
86703 |
0.08 |
chr1_90297327_90297723 | 0.60 |
LRRC8D |
leucine rich repeat containing 8 family, member D |
1727 |
0.42 |
chr17_35913810_35913961 | 0.60 |
SYNRG |
synergin, gamma |
11397 |
0.18 |
chr6_112083090_112083534 | 0.60 |
FYN |
FYN oncogene related to SRC, FGR, YES |
2192 |
0.42 |
chr3_178007468_178007787 | 0.60 |
KCNMB2 |
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
16907 |
0.28 |
chr1_156494924_156495366 | 0.59 |
ENSG00000238843 |
. |
3977 |
0.14 |
chrX_13782955_13783277 | 0.59 |
GPM6B |
glycoprotein M6B |
16008 |
0.18 |
chr11_1781297_1781822 | 0.59 |
AC068580.6 |
|
19 |
0.92 |
chr20_34078997_34079191 | 0.59 |
RP3-477O4.14 |
|
286 |
0.84 |
chr3_129323071_129323222 | 0.59 |
PLXND1 |
plexin D1 |
2515 |
0.25 |
chr15_68950586_68950737 | 0.59 |
CORO2B |
coronin, actin binding protein, 2B |
26334 |
0.24 |
chr17_46058462_46058613 | 0.59 |
CDK5RAP3 |
CDK5 regulatory subunit associated protein 3 |
4449 |
0.11 |
chr22_23226663_23227253 | 0.59 |
ENSG00000264824 |
. |
1489 |
0.13 |
chr4_6877165_6877316 | 0.59 |
TBC1D14 |
TBC1 domain family, member 14 |
33729 |
0.15 |
chr7_30503612_30503912 | 0.59 |
NOD1 |
nucleotide-binding oligomerization domain containing 1 |
14490 |
0.19 |
chr11_71249566_71249717 | 0.58 |
KRTAP5-8 |
keratin associated protein 5-8 |
570 |
0.65 |
chr17_46060168_46060319 | 0.58 |
CDK5RAP3 |
CDK5 regulatory subunit associated protein 3 |
6155 |
0.1 |
chr3_150992691_150993130 | 0.58 |
P2RY14 |
purinergic receptor P2Y, G-protein coupled, 14 |
3247 |
0.22 |
chr3_37934498_37934686 | 0.58 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
30927 |
0.15 |
chr22_31680259_31680536 | 0.58 |
PIK3IP1 |
phosphoinositide-3-kinase interacting protein 1 |
7984 |
0.11 |
chr6_22146922_22147073 | 0.58 |
ENSG00000222515 |
. |
61224 |
0.15 |
chr15_57656451_57656819 | 0.58 |
CGNL1 |
cingulin-like 1 |
12068 |
0.23 |
chr22_19760692_19760843 | 0.58 |
TBX1 |
T-box 1 |
16541 |
0.17 |
chr10_76672520_76672974 | 0.58 |
KAT6B |
K(lysine) acetyltransferase 6B |
74289 |
0.1 |
chr19_54851250_54851616 | 0.58 |
LILRA4 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 |
1012 |
0.36 |
chr13_32472814_32473222 | 0.58 |
EEF1DP3 |
eukaryotic translation elongation factor 1 delta pseudogene 3 |
53699 |
0.16 |
chr2_27182390_27182636 | 0.57 |
MAPRE3 |
microtubule-associated protein, RP/EB family, member 3 |
10967 |
0.14 |
chr5_80925841_80926179 | 0.57 |
SSBP2 |
single-stranded DNA binding protein 2 |
116474 |
0.07 |
chr1_82626673_82626824 | 0.57 |
LPHN2 |
latrophilin 2 |
181175 |
0.03 |
chr9_130668557_130668893 | 0.57 |
ST6GALNAC6 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
1116 |
0.29 |
chr15_75335761_75336119 | 0.57 |
PPCDC |
phosphopantothenoylcysteine decarboxylase |
324 |
0.87 |
chr3_112191691_112191842 | 0.57 |
BTLA |
B and T lymphocyte associated |
26439 |
0.21 |
chr2_238525899_238526558 | 0.57 |
LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
9991 |
0.16 |
chr13_109061568_109062120 | 0.57 |
ENSG00000223177 |
. |
108165 |
0.07 |
chr7_128500206_128500480 | 0.57 |
RP11-309L24.2 |
|
2337 |
0.2 |
chr16_27253790_27254558 | 0.57 |
NSMCE1 |
non-SMC element 1 homolog (S. cerevisiae) |
9775 |
0.17 |
chr9_93588989_93589216 | 0.57 |
SYK |
spleen tyrosine kinase |
668 |
0.83 |
chr7_50192918_50193134 | 0.57 |
AC020743.2 |
|
10607 |
0.23 |
chr14_21785801_21786038 | 0.57 |
RPGRIP1 |
retinitis pigmentosa GTPase regulator interacting protein 1 |
207 |
0.93 |
chr22_40342774_40343137 | 0.57 |
GRAP2 |
GRB2-related adaptor protein 2 |
134 |
0.96 |
chr15_42897715_42898344 | 0.57 |
STARD9 |
StAR-related lipid transfer (START) domain containing 9 |
30172 |
0.13 |
chr15_66907804_66908026 | 0.56 |
RP11-321F6.1 |
HCG2003567; Uncharacterized protein |
33387 |
0.12 |
chr16_12096718_12096869 | 0.56 |
RP11-166B2.7 |
|
25086 |
0.11 |
chr10_80459859_80460010 | 0.56 |
ENSG00000223243 |
. |
50425 |
0.19 |
chr7_37140670_37140985 | 0.56 |
ENSG00000221157 |
. |
4388 |
0.29 |
chr3_171160485_171160776 | 0.56 |
ENSG00000222506 |
. |
3315 |
0.28 |
chr2_70030512_70030780 | 0.56 |
GMCL1 |
germ cell-less, spermatogenesis associated 1 |
26128 |
0.16 |
chr14_101996676_101996827 | 0.56 |
ENSG00000258498 |
. |
30008 |
0.16 |
chr18_10284864_10285024 | 0.56 |
ENSG00000239031 |
. |
105053 |
0.07 |
chr11_114086673_114087539 | 0.56 |
NNMT |
nicotinamide N-methyltransferase |
41447 |
0.17 |
chr11_117886387_117886681 | 0.56 |
IL10RA |
interleukin 10 receptor, alpha |
29425 |
0.14 |
chr17_36743869_36744020 | 0.56 |
CTB-58E17.2 |
|
13358 |
0.13 |
chr21_32816172_32816580 | 0.56 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
99782 |
0.07 |
chr3_32408824_32409059 | 0.55 |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
24222 |
0.21 |
chr1_184122086_184122423 | 0.55 |
ENSG00000199840 |
. |
18703 |
0.25 |
chr17_7773138_7773452 | 0.55 |
LSMD1 |
LSM domain containing 1 |
11898 |
0.08 |
chr20_3088467_3088718 | 0.55 |
UBOX5-AS1 |
UBOX5 antisense RNA 1 |
1033 |
0.39 |
chr11_47276308_47276801 | 0.55 |
NR1H3 |
nuclear receptor subfamily 1, group H, member 3 |
2601 |
0.15 |
chr7_80261706_80261971 | 0.55 |
CD36 |
CD36 molecule (thrombospondin receptor) |
6122 |
0.33 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.7 | 2.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.6 | 1.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.6 | 2.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.6 | 1.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.6 | 2.8 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.5 | 2.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 1.6 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.5 | 0.5 | GO:0070254 | mucus secretion(GO:0070254) |
0.5 | 1.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 0.5 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.5 | 1.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 2.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 1.8 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.4 | 0.8 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.4 | 0.4 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.4 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.4 | 1.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 1.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 1.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 1.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.4 | 1.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 2.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.7 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.3 | 1.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 1.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 1.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 1.0 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.3 | 0.3 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 2.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.3 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of antigen processing and presentation(GO:0002577) positive regulation of antigen processing and presentation(GO:0002579) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 1.2 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.3 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.9 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.3 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 3.0 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.3 | 0.9 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.3 | 0.9 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.5 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 0.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 0.9 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 1.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 1.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.3 | 2.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 0.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 0.8 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.3 | 0.3 | GO:0001562 | response to protozoan(GO:0001562) |
0.3 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 0.3 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.3 | 1.3 | GO:0016265 | obsolete death(GO:0016265) |
0.3 | 2.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 0.5 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 1.3 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.3 | 1.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 0.8 | GO:0001714 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.5 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 1.0 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.2 | 1.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.7 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 1.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 1.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.2 | 0.5 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.2 | 0.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.7 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.4 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 1.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 2.2 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 1.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 1.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.2 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) negative regulation of phospholipid metabolic process(GO:1903726) |
0.2 | 3.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.4 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.2 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 0.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.2 | 0.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.0 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.2 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 1.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.7 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.7 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.2 | 0.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 1.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.5 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.2 | 0.2 | GO:0035710 | CD4-positive, alpha-beta T cell activation(GO:0035710) CD4-positive, alpha-beta T cell differentiation(GO:0043367) |
0.2 | 0.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 1.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.9 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.2 | 0.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 1.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 0.8 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.2 | GO:0019226 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.2 | 0.2 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.2 | 0.8 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.2 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.2 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.3 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.2 | 1.4 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.2 | 1.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.5 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.2 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.6 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.2 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 0.5 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 0.6 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 2.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.2 | 1.1 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.2 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.2 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 0.2 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.2 | 0.8 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.2 | 0.5 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.3 | GO:0031394 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.7 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.4 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 1.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 1.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.3 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.4 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.8 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.4 | GO:0046668 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.8 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.4 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.7 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.6 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.3 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.8 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.6 | GO:0032310 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) prostaglandin secretion(GO:0032310) |
0.1 | 0.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 1.2 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.2 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.1 | 0.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.6 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 1.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 1.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 1.7 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.6 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.2 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.4 | GO:0043049 | otic placode formation(GO:0043049) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.2 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.3 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.2 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.4 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.4 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.5 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 1.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.3 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.2 | GO:0003307 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.3 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.4 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0021548 | pons development(GO:0021548) |
0.1 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.5 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.1 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.6 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.5 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 1.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.3 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.3 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.4 | GO:0010543 | regulation of platelet activation(GO:0010543) negative regulation of platelet activation(GO:0010544) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
0.1 | 0.1 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.7 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0034763 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of transmembrane transport(GO:0034763) negative regulation of ion transmembrane transport(GO:0034766) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.8 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.2 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 1.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.0 | GO:0045762 | positive regulation of cyclase activity(GO:0031281) positive regulation of adenylate cyclase activity(GO:0045762) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) interleukin-1 production(GO:0032612) |
0.1 | 0.1 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.2 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:0045617 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.3 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.3 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.7 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.5 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 1.6 | GO:0070252 | actin-mediated cell contraction(GO:0070252) |
0.1 | 0.7 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.4 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) neural crest cell fate commitment(GO:0014034) |
0.1 | 0.1 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 0.1 | GO:0060004 | reflex(GO:0060004) righting reflex(GO:0060013) |
0.1 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.1 | 1.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 1.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.2 | GO:0009118 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.4 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.2 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
0.0 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.0 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.0 | 0.0 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.7 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 1.0 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.0 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 3.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:2001235 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.0 | 1.3 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.2 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.2 | GO:0007351 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.4 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.0 | 0.0 | GO:0032825 | natural killer cell differentiation(GO:0001779) regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 2.3 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 7.0 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.0 | 0.9 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.2 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) post-embryonic organ development(GO:0048569) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.4 | GO:0030814 | regulation of cAMP metabolic process(GO:0030814) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.0 | 0.0 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.0 | 0.0 | GO:0048857 | neural nucleus development(GO:0048857) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0010522 | regulation of calcium ion transport into cytosol(GO:0010522) |
0.0 | 0.1 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.2 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 0.0 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.2 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.9 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.0 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 1.1 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.4 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.6 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 3.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 1.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 0.7 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 0.3 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.2 | 2.8 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 0.6 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 0.5 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.0 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 5.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 3.4 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 3.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 11.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 3.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.1 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 2.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.1 | 1.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 1.0 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 3.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 1.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.4 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 1.2 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.0 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.4 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 14.1 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 2.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 1.9 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.6 | 1.7 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 1.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 2.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 1.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 0.4 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.4 | 1.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 1.5 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.3 | 1.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 1.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 1.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 1.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 1.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 1.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 1.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 0.8 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 0.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 0.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 4.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 2.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 2.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.2 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 2.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 0.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 2.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 1.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 1.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 3.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.6 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.2 | 0.6 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 0.2 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 1.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 9.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.5 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.2 | 2.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 1.4 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 3.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 3.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 2.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 2.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 2.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.4 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.8 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 2.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.8 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 1.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 2.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 7.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0032356 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 2.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 3.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.4 | GO:0016308 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 1.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.5 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.2 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.2 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.5 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 3.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 1.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.3 | GO:0070717 | poly(A) binding(GO:0008143) poly-purine tract binding(GO:0070717) |
0.0 | 0.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.4 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 5.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 5.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) glutamate receptor activity(GO:0008066) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 3.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.0 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 1.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 4.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 9.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 8.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 1.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 5.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 4.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 6.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 6.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 3.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 6.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.9 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 9.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 2.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 1.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.7 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.2 | 2.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 4.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 2.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 3.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 6.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 0.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 7.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 6.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 2.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 3.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 1.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.8 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 3.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.5 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 1.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 2.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |